Registration No. 333-137756

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Post-Effective Amendment No. 1

to

FORM S-3

REGISTRATION STATEMENT

UNDER THE

SECURITIES ACT OF 1933

 

 

MedCath Corporation

(Exact name of Registrant as specified in its Charter)

 

 

 

Delaware   56-2248952

(State or other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

10720 Sikes Place, Suite 200

Charlotte, North Carolina

  28277
(Address of principal executive offices)   (Zip Code)

 

 

James A. Parker

President and Chief Executive Officer

MedCath Corporation

10720 Sikes Place, Suite 200

Charlotte, North Carolina 28277

(Name and Address of Agent for Service)

(704) 815-7700

(Telephone number, Including Area Code, of Agent for Service)

 

 

Copy to:

Hal Levinson

Moore & Van Allen PLLC

100 North Tryon Street, Suite 4700

Charlotte, North Carolina 28202-4003

(704) 331-1050

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨   (Do not check if a smaller reporting company)    Smaller reporting company   ¨

 

 

 


EXPLANATORY NOTE

This Post-Effective Amendment No. 1 (the “Post-Effective Amendment”) to Registration Statement on Form S-3, No. 333-137756 (the “Registration Statement”) of MedCath Corporation (the “Company” or the “Registrant”) is being filed to terminate the effectiveness of the Registration Statement and to deregister 2,000,000 shares that were registered under the Registration Statement for sale by certain selling stockholders in a public offering through a group of underwriters and were unsold at the termination of the offering.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Charlotte, State of North Carolina, on August 28, 2012.

 

MEDCATH CORPORATION
By:  

/s/ James A. Parker

  James A. Parker
  President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated on the dates indicated.

 

Signature

  

Title

 

Date

/s/ James A Parker

James A. Parker

  

President, Chief Executive Officer and Director

( Principal Executive Officer )

  August 28, 2012

/s/ Lora Ramsey

Lora Ramsey

  

Vice President and Chief Financial Officer

( Principal Financial Officer )

  August 28, 2012

/s/ Woodrin Grossman

Woodrin Grossman

   Director   August 28, 2012

/s/ John T. Casey

John T. Casey

   Director   August 28, 2012

/s/ Jacque J. Sokolov

Jacque J. Sokolov, Md

   Director   August 28, 2012

/s/ Pamela G. Bailey

Pamela G. Bailey

   Director   August 28, 2012

/s/ Robert S. McCoy, Jr.

Robert S. McCoy, Jr.

   Director   August 28, 2012

/s/ James A. Deal

James A. Deal

   Director   August 28, 2012
Medcath (NASDAQ:MDTH)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Medcath 차트를 더 보려면 여기를 클릭.
Medcath (NASDAQ:MDTH)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Medcath 차트를 더 보려면 여기를 클릭.